Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.

Lau, Cia-Hin and Muniandy, Sekaran (2011) Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study. Cardiovascular Diabetology, 10 (1). p. 8. ISSN 1475-2840, DOI 21251282.

Full text not available from this repository.
Official URL: http://www.ncbi.nlm.nih.gov/pubmed/21251282

Abstract

The novel AR and IRAR indexes are cost-effective, precise, reproducible and reliable integrated diagnostic biomarkers of insulin sensitivity for screening subjects with increased risk of future development of T2DM and MS.

Item Type: Article
Funders: UNSPECIFIED
Uncontrolled Keywords: Novel adiponectin-resistin (AR); insulin resistance (IRAR); diabetes
Subjects: R Medicine > R Medicine (General)
Depositing User: Mr. Faizal Hamzah
Date Deposited: 25 Feb 2011 03:27
Last Modified: 25 Feb 2011 07:26
URI: http://eprints.um.edu.my/id/eprint/83

Actions (login required)

View Item View Item